A noninflammatory immune response in aged DNA Aβ42-immunized mice supports its safety for possible use as immunotherapy in AD patients

Research output: Contribution to journalArticle

11 Scopus citations


Aging in the immune system results in tendency to proinflammatory responses. Intradermal DNA immunization showed Th2 polarized noninflammatory immune responses. We tested here 18-month-old mice which were immunized with Aβ42 peptide, DNA Aβ42 trimer, or 2 different prime boost protocols identical to previous experiments. High Aβ42 antibody levels were found in aged mice which had received peptide immunizations (900μg/mL plasma), and in mice which had received peptide prime and DNA boost immunizations (500μg/mL), compared with antibodies in DNA Aβ42 immunized mice with 50μg/mL. Although we found T-cell proliferation and inflammatory cytokines in mice which had received peptide or prime boost immunization, these were not found in DNA-immunized mice. The results are concordant with proinflammatory responses because of immunosenescence and contraindicate the use of Aβ42 peptide immunizations or prime boost immunization protocols for the use in elderly Alzheimer's disease patients. DNA Aβ42 immunization only on the other hand does lead to effective levels of antibodies without inflammatory cytokine or T-cell responses in the aged animal model tested.

Original languageEnglish (US)
Pages (from-to)1274-1281
Number of pages8
JournalNeurobiology of Aging
Issue number3
StatePublished - Mar 1 2015



  • Aging
  • Alzheimer disease
  • Aβ42 immunotherapy
  • Immunosenescence
  • Inflammaging
  • Inflammation

ASJC Scopus subject areas

  • Neuroscience(all)
  • Aging
  • Clinical Neurology
  • Developmental Biology
  • Geriatrics and Gerontology

Cite this